Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63986 publications
Should we be optimistic for the development of new psoriasis therapies?
Journal: The Journal of dermatological treatment
Published: December 16, 2025
Comparative Efficacy and Safety of Laser Versus Chemical Skin Peeling in Skin Rejuvenation: A Systematic Review and Meta-Analysis.
Journal: Plastic and reconstructive surgery
Published: December 16, 2025
Tildrakizumab in real-world Chinese psoriasis: efficacy-safety profiles from a 28-week retrospective cohort with geriatric, late-onset and metabolic syndrome stratification.
Journal: The Journal of dermatological treatment
Published: December 16, 2025
Large language model-assisted natural language processing reveals stigmatizing discourse regarding psoriasis on social media.
Journal: JAAD international
Published: December 15, 2025
Cell population data as predictive biomarkers for biologic therapy response in psoriasis.
Journal: Expert opinion on biological therapy
Published: December 15, 2025
Dual targeting in Spondyloarthritis: rethinking cytokine redundancy and the quest for durable remission.
Journal: Expert opinion on pharmacotherapy
Published: December 15, 2025
Comment on: "Nociplastic pain in axial spondyloarthritis and psoriatic arthritis: role of jak kinases in immunopathology and therapeutic impact of jak inhibitors" by Horbal and Maksymowych.
Journal: Expert review of clinical immunology
Published: December 14, 2025
Nanovesicles-Enabled Concurrent Delivery of Cyclosporine and Vitamin D for Topical Treatment of Psoriasis.
Journal: Journal of drug targeting
Published: December 14, 2025
Corrigendum to "Targeting the epigenetic regulator bromodomain-containing protein 4 by BRD4 siRNA lipoplexes and PFI-1 in psoriasis" [Int. Immunopharmacol. 167 (2025) 115753].
Journal: International immunopharmacology
Published: December 13, 2025
What is the optimal sequential therapy after secondary IL-17A inhibitor failure in psoriasis: switching to an IL-23 inhibitor or to another IL-17A inhibitor?
Journal: The Journal of dermatological treatment
Published: December 11, 2025
Deucravacitinib could be an effective and safe choice in patients affected with psoriasis and atopic dermatitis (Psorema)?
Journal: Italian journal of dermatology and venereology
Published: December 11, 2025
Psoriasis intervention by Huai'er (): unveiling novel targetsnetwork pharmacology.
Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: December 11, 2025
Last Updated: 01/07/2026